Logo Unión Europea

CORMPOI: Development of Carbon Monoxide Releasing Molecules for the Treatment of Postoperative Ileus

R&D Project COMPOI

The biotechnology company Alfama, with sites in Lisbon and Boston, is the world leader in CO-releasing molecules (CORMs), compounds with powerful vasodilatation activity. GalChimia has partnered with Alfama to develop CORMs for Postoperative Ileus (POI), a condition usually found in patients who have undergone surgery. GalChimia’s synthetic expertise complements the Alfama’s deep biological knowledge of CORMs.

Logo Eurostar
Logo Galchimia letters

Subscribe to stay updated on the latest advances in organic synthesis and GalChimia’s good chemistry

     "*" mandatory

    I agree, and accept the data protection policy